Vanguard Personalized Indexing Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Vanguard Personalized Indexing Management's CLB Position: Q2 2026 in Review
Vanguard Personalized Indexing Management increased its Core Laboratories (CLB) stake by 18% in Q2 2026, buying an estimated $31K and bringing the position to 13,929 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.
Vanguard Personalized Indexing Management first reported a position in CLB in Q1 2024 and has held it in 9 quarters since. The position peaked at $282K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Vanguard Personalized Indexing Management held 13,929 shares of Core Laboratories worth $162K as of Q2 2026.
- Vanguard Personalized Indexing Management bought 2,171 Core Laboratories shares in Q2 2026, an estimated $31K.
- Core Laboratories made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1966 holding.
- Vanguard Personalized Indexing Management first reported a position in Core Laboratories in Q1 2024 and has held it in 9 quarters since.
- Vanguard Personalized Indexing Management's Core Laboratories position peaked at $282K in Q2 2024.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.